Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 602-608

  Lengerova, Martina ^a,b   Kocmanova, Iva ^a   Racil, Zdenek ^a   Hrncirova, Kristyna ^a   Pospisilova, Sarka ^a,b   Mayer, Jiri ^a,b   Najvar, Laura K ^c,d   Wiederhold, Nathan P ^c,e   Kirkpatrick, William R ^c,d   Patterson, Thomas F ^c,d  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDO 1,3 BETA GLUCANASE; GALACTOMANNAN; INTERNAL TRANSCRIBED SPACER; RIBOSOME DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FUNGAL BURDEN; FUNGAL DETECTION; FUNGAL PHENOMENA AND FUNCTIONS; GUINEA PIG; INTERMETHOD COMPARISON; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE NESTED REAL TIME POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANIMALS; ASPERGILLUS FUMIGATUS; BETA-GLUCANS; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; GUINEA PIGS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG; MALE; MANNANS; MYCOLOGY; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84857428275     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05356-11     Document Type: Article

References (28)

1. Becker MJ, et al. 2003. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 121:448-457. (Pubitemid 36628336)
2. Christie JD. 2003. Diagnosis of invasive mold infection. Is PCR the answer? Am. J. Clin. Pathol. 119:38-44.
3. De Pauw B, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
4. Espy MJ, et al. 2006. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19:165-256. (Pubitemid 43158452)
5. Ferns RB. 2006. Evaluation of the role of real-time PCR in the diagnosis of invasive aspergillosis. Leuk. Lymphoma 47:15-20. (Pubitemid 43101719)
6. Francesconi A, et al. 2006. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J. Clin. Microbiol. 44:2475-2480. (Pubitemid 44092414)
7. Graybill JR, Kaster SR. 1984. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. Am. Rev. Respir. Dis. 129:292-295. (Pubitemid 14189172)
8. Khan ZU, Ahmad S, Theyyathel AM. 2008. Diagnostic value of DNA and (1→3)-D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum. 47301-0. J. Med. Microbiol. 57:36-42.
9. Klingspor L, Loeffler J. 2009. Aspergillus PCR formidable challenges and progress. Med. Mycol. 47(Suppl. 1):S241-S247.
10. Maertens J, et al. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688-1693.
11. Meersseman W, et al. 2008. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177:27-34.
12. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:89-96.
13. Mennink-Kersten MASH, Ruegebrink D, Wasei N, Melchers WJG, Verweij PE. 2006. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-{beta}-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 44:1711-1718. (Pubitemid 43726259)
14. Miceli MH, et al. 2008. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin. Infect. Dis. 46:1412-1422. (Pubitemid 351589942)
15. Morton CO, et al. 2010. Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. J. Med. Microbiol. 59:408-413.
16. National Academy of Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
17. Neofytos D, et al. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48:265-273.
18. Nierman WC, et al. 2005. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438:1151-1156. (Pubitemid 41831684)
19. Nogva HK, Rudi K. 2004. Potential influence of the first PCR cycles in real-time comparative gene quantifications. Biotechniques 37:246-248, 250-253.
20. Pagano L, Caira M, Valentini CG, Posteraro B, Fianchi L. 2010. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Blood Rev. 24:51-61.
21. Patterson TF. 2005. The future of animal models of invasive aspergillosis. Med. Mycol. 43(Suppl. 1):S115-S119. (Pubitemid 41038558)
22. Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. 2007. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J. Clin. Microbiol. 45:906-914. (Pubitemid 46427710)
23. Sheppard DC, et al. 2006. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin. Microbiol. Infect. 12:376-380. (Pubitemid 43337528)
24. Sheppard DC, et al. 2004. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 48:1908-1911. (Pubitemid 38544412)
25. Tuon FF. 2007. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev. Iberoam. Micol. 24:89-94. (Pubitemid 47025141)
26. Vallor AC, et al. 2008. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob. Agents Chemother. 52:2593-2598. (Pubitemid 351915692)
27. Wessa P. 2011. Free statistics software, Office for Research Development and Education, version 1.1.23-r7. http://www.wessa.net/.
28. Zhao Y, et al. 2010. Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J. Clin. Microbiol. 48:1378-1383.